These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9050215)

  • 1. Synthesis of N,N'-bis-aminoalkyl-substituted derivatives of bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide with potential anxiolytic activity.
    Turło J; Zawadowski T
    Farmaco; 1996 Dec; 51(12):815-8. PubMed ID: 9050215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological screening of some N,N'-bis-[4-(4-aryl-1-piperazinyl)butyl]-substituted derivatives of 1,8-dimethylbicyclo-[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide.
    Turło J; Zawadowski T; Rump S; Jakowicz I; Gidyńska T; Gałecka E
    Pol J Pharmacol; 1994; 46(5):451-5. PubMed ID: 7894533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of new N-substituted benzodiazepine derivatives with potential anxiolytic activity.
    Kossakowski J; Zawadowski T; Turło J
    Acta Pol Pharm; 1997; 54(6):483-5. PubMed ID: 9604696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XXIV. Derivatives of N-hydroxy-1-methoxybicyclo[2.2.2]oct-5-ene-2,3-dicarboximide.
    Kossakowski J; Krawiecka M
    Acta Pol Pharm; 2003; 60(3):177-82. PubMed ID: 14556485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and serotonin binding site studies of some conformationally restricted indolylethylamine analogues based on 2-amino-3-(3'-indolyl)bicyclo[2.2.2]octane.
    Schlecht MF; Tsarouhtsis D; Lipovac MN; Debler EA
    J Med Chem; 1990 Jan; 33(1):386-94. PubMed ID: 2136918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new derivatives of 1,2,3,4,7-pentamethylbicyclo[2.2.1]hept-2-ene-5,6-dicarboximide with an expected anxiolytic activity.
    Kossakowski J; Kuśmierczyk J
    Pharmazie; 2000 Jan; 55(1):5-8. PubMed ID: 10683863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
    Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XIII. Derivatives of 1-methoxybicyclo[2.2.2]oct-5-ene-2,3-dicarboximide.
    Kossakowski J; Krawiecka M
    Acta Pol Pharm; 2000 Nov; 57 Suppl():53-6. PubMed ID: 11293265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents.
    Alfredo BA; Ofir P
    Eur J Pharmacol; 2005 Jan; 508(1-3):155-8. PubMed ID: 15680266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new N-[4-(4-aryl- and 4-heteroaryl-1-piperazinyl)butyl]derivatives of 1-methyl-5-oxobicyclo[2.2.1]heptane-2,3-dicarboximide with an expected anxiolytic activity.
    Kossakowski J; Zawadowski T; Kuśmierczyk J
    Acta Pol Pharm; 1998; 55(4):315-8. PubMed ID: 9821397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of umespirone as a potential anxiolytic and antipsychotic agent.
    Barnes NM; Costall B; Domeney AM; Gerrard PA; Kelly ME; Krähling H; Naylor RJ; Tomkins DM; Williams TJ
    Pharmacol Biochem Behav; 1991 Sep; 40(1):89-96. PubMed ID: 1685786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. II. Discrimination from typical neuroleptics and benzodiazepine-like minor tranquilizers.
    Krähling H; Fuchs A; Ruhland M; Schön U; Mol F; Tulp M
    Pharmacopsychiatry; 1988 Nov; 21(6):399-401. PubMed ID: 2907650
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XV. Derivatives of 2-ethyl-1.4-dimethoxy-dibenzo[e.h]bicyclo[2.2.2] octane-2.3-dicarboximide.
    Kossakowski J; Maleszewska E
    Acta Pol Pharm; 2000 Nov; 57 Suppl():47-50. PubMed ID: 11293262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVI. Derivatives of 1-acetoxy-7,7-dimethylbicyclo[2.2.2]octan-5-one-2,3-dicarboximide.
    Kossakowski J; Hejchman E
    Acta Pol Pharm; 2003; 60(1):61-6. PubMed ID: 12848369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of new n-substituted cyclic imides with potential anxiolytic activity. XVIII. Derivatives of 1-bromo-dibenzo[e.h]bicyclo[2.2.2] octane-2.3-dicarboximide.
    Kossakowski J; Perliński M
    Acta Pol Pharm; 2001; 58(4):257-62. PubMed ID: 11693729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XI. Derivatives of 7-diphenylmethylenebicyclo[2.2.1]hept-2-ene-5,6-dicarboximide.
    Kossakowski J; Hejchman E
    Acta Pol Pharm; 2000 Nov; 57 Suppl():57-60. PubMed ID: 11293266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. I. Antipsychotic and anxiolytic activity in comparison with chlorpromazine, clozapine, diazepam and buspirone.
    Ruhland M; Krähling H; Fuchs A; Schön U
    Pharmacopsychiatry; 1988 Nov; 21(6):396-8. PubMed ID: 2907649
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of new N-substituted cyclic imides with potential anxiolytic activity. XXV. Derivatives of halogenodibenzo[e.h]bicyclo[2.2.2]octane-2.3-dicarboximide.
    Kossakowski J; Perliński M
    Acta Pol Pharm; 2003; 60(3):183-90. PubMed ID: 14556486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.